FDA Leadership Shakeup: Trump Plans to Fire Commissioner Makary

AI Summary

The White House intends to replace FDA Commissioner Marty Makary amid ongoing agency turmoil. President Trump has reportedly signed off on this decision, although specific reasons for the ousting remain unclear. This leadership change could influence FDA regulations and approval processes, particularly in the context of flavored vape products where pressure has been applied for quicker approvals. Market reactions may vary based on investor sentiment towards regulatory stability and its impact on pharmaceutical stocks.